Purpura, Thrombocytopenic, Idiopathic - 25 Studies Found
Withdrawn |
: Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia : Purpura, Thrombocytopenic, Idiopathic : 2011-03-17 : Drug: rhIL-11 Recombinant Human Interleukin-11 (rhIL-11) Combinating Low-dose Rituximab |
Recruiting |
: A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia : Immune Thrombocytopenia : 2012-03-29 : Drug: Decitabine Decitabine 3.5mg/m2,ivdrip,qd x 3d, every four weeks for one cycle. It wi |
Recruiting |
: Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia : Immune Thrombocytopenia : 2017-01-16 :
|
Completed |
: Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) :
|
Completed |
: An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers :
|
Completed |
: Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) :
|
Completed |
: The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. :
|
Withdrawn |
: The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia : Immune Thrombocytopenia : 2013-04-03 |
Recruiting |
: Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia : Immune Thrombocytopenia : 2014-11-17 :
|
Recruiting |
: End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia : Immune Thrombocytopenia : 2011-06-13 : Drug: Discontinuation of eltrombopag Observation of subjects as they discontinue the use of eltrombopag |